MedMira Inc. MIR.V

MIR.V Company Overview

MedMira Inc. is a Canadian biotechnology company operating in the in vitro diagnostics industry, with a primary focus on the development, manufacture, and commercialization of rapid point-of-care diagnostic tests for infectious diseases. The company’s core offerings address global public health needs, particularly in HIV, syphilis, and other sexually transmitted infections, where rapid and decentralized testing is critical. MedMira generates revenue primarily through the sale and licensing of its proprietary rapid diagnostic technologies to healthcare providers, distributors, and public health organizations.

Founded in 1989, MedMira is headquartered in Halifax, Nova Scotia, and has evolved from an early-stage diagnostics developer into a specialized provider of rapid testing solutions. The company’s strategic positioning centers on its proprietary Rapid Vertical Flow (RVF) technology, which is designed to deliver results quickly without the need for laboratory infrastructure. This positions MedMira to serve remote, resource-limited, and non-traditional clinical settings where conventional diagnostics are less accessible.